Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Medicines for Europe statement on COVID-19 (‘coronavirus’)

13 March 2020

Open

European Industries welcome an important industry focus from the European Commission

11 March 2020

Open

Coordination with industry on potential impact of Covid-19 on medicines manufacturing and supplies in Europe

10 March 2020

Open

Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy

3 March 2020

Equitable and sustainable access to medicines is a concern across […]

Read more

Impact of COVID-19 on active ingredient and medicines manufacturing and supplies in Europe

18 February 2020

Open

Resolving and mitigating medicine shortages in the EU

10 February 2020

Drug shortages can greatly impact patients and the pharmaceutical industry. […]

Read more

The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe

7 February 2020

Open

Arun Narayan – Chairman, Value Added Medicines Group, Medicines for Europe

31 January 2020

Arun Narayan is the Chairman of the Value Added Medicines […]

Read more

Time to modernise the EU pharmaceutical regulatory framework to deliver on access

30 January 2020

To maintain its leadership in pharmaceutical regulatory science, the EU […]

Amsterdam

Smart Pharmacovigilance Essential for Patient Safety

29 January 2020

Medicines are developed and manufactured to help patients so, it […]

Read more

Subscribe to our newsletter